BR, v. T. V., WM, H., C, L., LAA, B., & KMA, D. (2025). Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors. Endocrine pathology, 36(1), 3. https://doi.org/10.1007/s12022-025-09848-1
Chicago Style (17th ed.) CitationBR, van T Veld, Hackeng WM, Luchini C, Brosens LAA, and Dreijerink KMA. "Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors." Endocrine Pathology 36, no. 1 (2025): 3. https://doi.org/10.1007/s12022-025-09848-1.
MLA (9th ed.) CitationBR, van T Veld, et al. "Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors." Endocrine Pathology, vol. 36, no. 1, 2025, p. 3, https://doi.org/10.1007/s12022-025-09848-1.